Nerve growth factor, ganglioside and vitamin E reverse glutamate cytotoxicity in hippocampal cells

European Journal of Pharmacology

Volumn 367, Issue 1, 1999, Pages 107-112

  Cunha, Geanne M A ^a   Moraes, Renata A ^a   Moraes, Germana A ^a   França Jr , Marcondes C ^a   Moraes, M Odorico ^a   Viana, Glauce S B ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Ganglioside GM1; Glutamate; Hippocampal cell; NGF (nerve growth factor); Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; GANGLIOSIDE GM1; GLUTAMIC ACID; NERVE GROWTH FACTOR;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; HIPPOCAMPUS; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; GANGLIOSIDES; GLUTAMIC ACID; HIPPOCAMPUS; MALE; NERVE GROWTH FACTORS; RATS; RATS, WISTAR; VITAMIN E;

EID: 0032965767     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00942-X     Document Type: Article

References (50)

1. Akaike S., Tamura Y., Sato Y., Ozaki K., Matsuoka R., Muira S., Yoshinaga T. Cholecystokinin-induced protection of cultured cortical neurons against glutamate neurotoxicity. Brain Res. 557:1991;303-307.
2. Brenner E.G., Schlessinger J., Hakomori S. Ganglioside mediated modulation of cell growth: specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor. J. Biol. Chem. 261:1986;2434-2440.
3. Choi D.W. Ionic dependence of glutamate neurotoxicity. J. Neurosci. 7:1987;369-379.
4. Cuello A.C. Glycosphingolipids that can regulate nerve growth and repair. Adv. Pharmacol. 21:1990;1-50.
5. Cunha G.M.A., Moraes M.O., Paraiba D.B., Lyra K.P., Viana G.S.B. Effects of gangliosides, ouabain and arachdonic acid on glutamate cytotoxicity in PC12 cells. Biol. Pharm. Bull. 20:1997;149-152.
6. Deupree D.L., Tang X.W., Yarom M., Dickman E., Kirch R.D., Schloss J.V., Wu J.Y. Studies of NMDA and non-NMDA-mediated neurotoxicity in cultured neurons. Neurochem. Int. 29:1996;255-261.
7. Duchemin A.M., Neff N.H., Hadjiconstantinou M. GM1 increases the content and mRNA of NGF in the brain of aged rats. NeuroReport. 8:1997;3823-3827.
8. 1 enhances induction by nerve growth factor of a putative dimer of TrkA. J. Neurochem. 68:1997;2348-2355.
9. Favaron M., Manev H., Alho H., Bertolino M., Ferret B., Guidotta A., Costa E. Gangliosides prevent glutamate and kainate neurotoxicity in primary neuronal cultures of neonatal rat cerebellum and cortex. Proc. Natl. Acad. Sci. USA. 85:1988;7351-7355.
10. Favit A., Nicoletti F., Scapagnini P.L. Ubiquinone protects cultured neurons against spontaneous and excitotoxic-induced degeneration. J. Cereb. Blood Flow Metab. 12:1992;638-645.
11. Ferrari G., Fabris M., Gorio A. Gangliosides enhance neurite outgrowth in PC12 cells. Dev. Brain Res. 8:1983;215-221.
12. Ferrari G., Fabris M., Fiori M.G., Gabellini N., Volonte C. Gangliosides prevent inhibition by K-252a of NGF responses in PC12 cells. Dev. Brain Res. 65:1992;293-302.
13. Frim M.D., Short P.M., Rosenberg S.W., Simpson J., Xandra A.B., Breakfield O., Isacson O. Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatum. J. Neurosurg. 78:1993;267-273.
14. Fusco M., Vantini G., Schiavo N., Zannoti A., Zanoni R., Facci L., Skaper S.D. Gangliosides and neurotrophic factors in neurodegenerative diseases: from experimental findings to clinical perspectives. Ann. New York Acad. Sci. 695:1993;314-317.
15. Greene L.A., Shooter E.M. The nerve growth factor: biochemistry, synthesis and mechanism of action. Annu. Rev. Neurosci. 3:1980;353-402.
16. 1 ganglioside: in vivo and in vitro trophic actions on central neurotransmitter systems. J. Neurochem. 70:1998;1335-1345.
17. Hall E.D., Yonkers P.O., Horan K.L., Braughler J.M. Correlation between attenuation of post-traumatic spinal cord ischemia and preservation of tissue vitamin E by the 21-aminosteroid.U74006F. Evidence for an in vivo antioxidant mechanism. J. Neurotrauma. 6:1989;169-176.
18. Halliwell B. Oxidants and human disease: some new concepts. FASEB J. 1:1987;358-364.
19. Hynds D.L., Burry R.W., Yates A.J. Gangliosides inhibit growth factor-stimulated neurite outgrowth in SH-SY5Y human neuroblastoma cells. J. Neurosci. Res. 47:1997;617-625.
20. Jesberger J.A., Richardson J.S. Oxygen free radicals and brain dysfunction. Int. J. Neurosci. 57:1991;1-17.
21. Johnson J.W., Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature. 325:1987;529-531.
22. Kaplan D.R., Hempstead B.L., Martin-Janca D., Chao M.V., Parada L.F. The TrK proto-oncogene product: a signal transducing receptor for nerve growth factor. Science, Washington, DC. 252:1991;554-558.
23. 2+ in focal cortical stroke: GM1 ganglioside reduces ischemic injury. J. Neurosci. Res. 30:1991;512-520.
24. Klein R., Jing S.F.Q., Nanduri V., O'Rourk E., Barbacid M. The TrK proto-oncogene encodes a receptor for nerve growth factor. Cell. 65:1991;189-197.
25. Lafon-Cazal M., Pietri S., Culcasi M., Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature. 364:1993;535-537.
26. Levi A., Alleman S. The mechanism of action of nerve growth factor. Annu. Rev. Pharmacol. Toxicol. 31:1991;205-228.
27. Levy D.I., Sucher N.J., Lipton S.A. Redox modulation of NMDA receptor-mediated toxicity in mammalian central neurons. Neurosci. Lett. 110:1990;291-296.
28. +, ATPase after nigrostriatal transection. Brain Res. 377:1986;292-297.
29. Li R., Kong Y., Ladisch S. Nerve growth factor-induced neurite formation in PC12 cells is independent of endogenous cellular gangliosides. Glycobiology. 8:1998;597-603.
30. MacGregor D.G., Higgins M.J., Jones P.A., Maxwell W.L., Wattson M.W., Graham D.I., Stone T.W. Ascorbate attenuates the systemic kainate-induced neurotoxicity in the rat hippocampus. Brain Res. 727:1996;133-144.
31. Manev H., Favaron M., Vieini S., Guidotti A., Costa E. Glutamate-induced neuronal death in primary cultures of cerebellar granule cells: protection by synthetic derivatives of endogenous sphingolipids. J. Pharmacol. Exp. Ther. 252:1990;419-427.
32. Mattson, M.P., Mark, R.J., 1996. Excitotoxicity and excitoprotection in vitro. In: Siesjo, B.K., Willoch, T. (Eds.), Advances in Neurology: Vol. 71. Cellular and Molecular Mechanisms of Ischemic Brain Damage. Lippincott-Raven, Philadelphia.
33. Mattson M.P., Scheff S.W. Endogenous neuroprotection factors and traumatic brain injury: mechanisms of action and implications for therapy. J. Neurotrauma. 11:1994;3-13.
34. Mattson M.P., Guthrie P.B., Hayes B.C., Kater S.B. Roles for mitotic history in the generation and degeneration of neuroarchitecture. J. Neurosci. 9:1989;1223-1230.
35. Mattson M.P., Cheng B., Smith-Swintosky V.L. Growth factor-mediated protection from excitoxicity and disturbances in calcium and free radical metabolism. Semin. Neurosci. 5:1993;295-307.
36. 2+] and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 65:1995;1740-1751.
37. Monyer H., Hartley D.M., Choi D.W. 21-aminosteroids attenuate excitotoxic neuronal injury in cortical cell cultures. Neuron. 5:1990;121-126.
38. 1-enhanced neuritogenesis. J. Neurochem. 68:1997;596-600.
39. Nistico G., Ciriolo M.R., Fiskin D., Iannone M., DeMartino A., Rotilio G. NGF restores decrease in catalase activity and increases superoxide dismutase and glutathione peroxidase activity in the brain of aged rats. Free Radic. Biol. Med. 12:1992;177-181.
40. 2+ in toxic cell killing. Trends Pharmacol. Sci. 10:1989;281-285.
41. Pan Z., Perez-Polo R.L., Bero C. Deferoxamine post-treatment reduces ischemic brain injury in neonatal rats. Stroke. 25:1994;1039-1045.
42. Prehn J.H.M., Backhauss C., Krieglstein J. Transforming growth factor-β prevents glutamate toxicity in rat neocortical cell cultures and protects mouse from ischemic injury in vivo. J. Cereb. Blood Flow Metab. 13:1993;521-525.
43. 2+ homeostasis, cell death, proliferation and differentiation. Chem. Biol. Interact. 77:1991;1-23.
44. Schlessinger J., Ulbrich A. Growth factor signalling by receptor tyrosine kinases. Neuron. 9:1992;383-391.
45. Schubert D., Kimura H., Meher P. Growth factors and vitamin E modify neuronal glutamate toxicity. Proc. Natl. Acad. Sci. USA. 89:1992;8264-8267.
46. Shigeno T., Mina T., Takakura K., Graham D.I., Kato G., Hashimoto Y., Furukawa S. Amelioration of delayed neuronal death in hippocampal by nerve growth factor. J. Neurosci. 11:1991;2914-2919.
47. Shimolama S., Ogawa N., Tamura Y., Akaika A., Tsukahara T., Iwata H., Kimura J. Protective effect of nerve growth factor against glutamate-induced neurotoxicity in cultured cortical neurons. Brain Res. 632:1993;296-302.
48. Skaper S.D., Leon A., Facci L. Death of cultured hippocampal pyramidal neurons induced by pathological activation of N-methyl-D-aspartate receptors is reduced by monosialogangliosides. J. Pharmacol. Exp. Ther. 259:1991;452-457.
49. 2+ flux in mammalian central neurons. Neuropharmacol. Neurotoxicol. 1:1990;29-32.
50. Zhang Y., Tatsuno T., Carney J., Mattson M.P. Basic FGF, NGF and IGFs protect hippocampal and cortical neurons against iron-induced degeneration. J. Cereb. Blood Flow Metab. 13:1993;378-388.